Patents by Inventor Frank Mao

Frank Mao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ARTIFICIAL INTELLIGENCE METHOD FOR DETERMINING THERAPY RECOMENDATION FOR INDIVIDUALS WITH NEURODEVELOPMENTAL DISORDERS
    Publication number: 20240120067
    Abstract: A method implemented via a computing device. The method may include receiving, by the computing device, data associated with a subject having a neurodevelopmental disorder (NDD). The data associated with the subject may include demographic data, schooling data, family medical data, prior therapy data, observational assessment data, medication data, goals data, or combinations thereof. The method may further include evaluating, by the computing device, the data associated with the subject via a neurodevelopmental disorder treatment recommendation (NDDTR) model. The NDDTR model may evaluate the data associated with the subject to determine a therapy recommendation. The therapy recommendation may include a standard of care. The NDD may be ASD.
    Type: Application
    Filed: September 29, 2022
    Publication date: April 11, 2024
    Inventors: Jenish MAHARJAN, Anurag GARIKIPATI, Madalina CIOBANU, Frank DINENNO, Qingqing MAO
  • Composition for reducing blood lipids
    Publication number: 20070178172
    Abstract: A composition for reducing the blood lipids is disclosed. The composition includes the lactoferrin and a trivalent chromium compound. The trivalent chromium compound of the present invention is selected from a group consisting of chromium (III) chloride hexahydrate, chromium (III) chloride, chromium (III) acetate, chromium (III) sulfate, chromium picolinate, chromium nicotinate, inorganic salts of trivalent chromium, organic salts of trivalent chromium, and combinations thereof. The present invention also discloses a method for reducing the blood lipids of an acceptor.
    Type: Application
    Filed: March 30, 2007
    Publication date: August 2, 2007
    Applicant: MAXLUCK BIOTECHNOLOGY CORP.
    Inventors: Frank Mao, Fan-Chin Hsiao, Yi-Chung Chiang
  • Composition for preventing and treating cardiovascular disorders
    Publication number: 20070010426
    Abstract: A composition for preventing and treating cardiovascular disorders is disclosed. The composition includes the lactoferrin and a trivalent chromium compound. The trivalent chromium compound of the present invention is selected from a group consisting of chromium (III) chloride hexahydrate, chromium (III) chloride, chromium (III) acetate, chromium (III) sulfate, chromium picolinate, chromium nicotinate, inorganic salts of trivalent chromium, organic salts of trivalent chromium, and combinations thereof. The present invention also discloses a method for preventing and treating cardiovascular disease of an acceptor.
    Type: Application
    Filed: September 6, 2005
    Publication date: January 11, 2007
    Applicant: Maxluck Biotechnology Corp.
    Inventors: Frank Mao, Wen-Ying Chen, Yi-Chung Chiang, Ling-Hui Cheng Chiang
  • Composition for reducing blood lipids
    Publication number: 20060030519
    Abstract: A composition for reducing the blood lipids is disclosed. The composition includes the lactoferrin and a trivalent chromium compound. The trivalent chromium compound of the present invention is selected from a group consisting of chromium (III) chloride hexahydrate, chromium (III) chloride, chromium (III) acetate, chromium (III) sulfate, chromium picolinate, chromium nicotinate, inorganic salts of trivalent chromium, organic salts of trivalent chromium, and combinations thereof. The present invention also discloses a method for reducing the blood lipids of an acceptor.
    Type: Application
    Filed: May 26, 2005
    Publication date: February 9, 2006
    Applicant: Maxluck Biotechnology Corp.
    Inventors: Frank Mao, Fan-Chin Hsiao, Yi-Chung Chiang